Genome-minimized Streptomyces host for the heterologous expression of secondary metabolism
Top Cited Papers
- 25 January 2010
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 107 (6) , 2646-2651
- https://doi.org/10.1073/pnas.0914833107
Abstract
To construct a versatile model host for heterologous expression of genes encoding secondary metabolite biosynthesis, the genome of the industrial microorganism Streptomyces avermitilis was systematically deleted to remove nonessential genes. A region of more than 1.4 Mb was deleted stepwise from the 9.02-Mb S. avermitilis linear chromosome to generate a series of defined deletion mutants, corresponding to 83.12–81.46% of the wild-type chromosome, that did not produce any of the major endogenous secondary metabolites found in the parent strain. The suitability of the mutants as hosts for efficient production of foreign metabolites was shown by heterologous expression of three different exogenous biosynthetic gene clusters encoding the biosynthesis of streptomycin (from S. griseus Institute for Fermentation, Osaka [IFO] 13350), cephamycin C (from S. clavuligerus American type culture collection (ATCC) 27064), and pladienolide (from S. platensis Mer-11107). Both streptomycin and cephamycin C were efficiently produced by individual transformants at levels higher than those of the native-producing species. Although pladienolide was not produced by a deletion mutant transformed with the corresponding intact biosynthetic gene cluster, production of the macrolide was enabled by introduction of an extra copy of the regulatory gene pldR expressed under control of an alternative promoter. Another mutant optimized for terpenoid production efficiently produced the plant terpenoid intermediate, amorpha-4,11-diene, by introduction of a synthetic gene optimized for Streptomyces codon usage. These findings highlight the strength and flexibility of engineered S. avermitilis as a model host for heterologous gene expression, resulting in the production of exogenous natural and unnatural metabolites.Keywords
This publication has 39 references indexed in Scilit:
- Genomic basis for natural product biosynthetic diversity in the actinomycetesNatural Product Reports, 2009
- Antibiotic Overproduction by rpsL and rsmG Mutants of Various ActinomycetesApplied and Environmental Microbiology, 2009
- Organization of the Biosynthetic Gene Cluster for the Polyketide Antitumor Macrolide, Pladienolide, inStreptomyces platensisMer-11107Bioscience, Biotechnology, and Biochemistry, 2008
- Engineered production of iso-migrastatin in heterologous Streptomyces hostsBioorganic & Medicinal Chemistry, 2008
- Genome Sequence of the Streptomycin-Producing MicroorganismStreptomyces griseusIFO 13350Journal of Bacteriology, 2008
- Identification and functional analysis of genes controlling biosynthesis of 2-methylisoborneolProceedings of the National Academy of Sciences, 2008
- Splicing factor SF3b as a target of the antitumor natural product pladienolideNature Chemical Biology, 2007
- Complete genome sequence and comparative analysis of the industrial microorganism Streptomyces avermitilisNature Biotechnology, 2003
- Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2)Nature, 2002
- Overexpression of the Nocardia lactamduransα‐Aminoadipyl‐Cysteinyl‐Valine Synthetase in Streptomyces lividansEuropean Journal of Biochemistry, 1996